Evaluation and updating of the osiris expert system for identification of Escherichia coli β-lactam resistance phenotypes

Journal of Clinical Microbiology

Volumn 43, Issue 4, 2005, Pages 1846-1850

  Bert, Frédéric ^a   Juvin, Manette ^b   Ould Hocine, Zahia ^c   Clarebout, Gervais ^b   Keller, Emmanuelle ^b   Lambert, Nicole ^a   Arlet, Guillaume ^c  

^a BEAUJON HOSPITAL   (France)

^b Bio Rad   (France)

^c HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; OXACILLIN; PENICILLINASE;

ACCURACY; ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ARTICLE; AUTOMATION; BACTERIAL GENETICS; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SYNTHESIS; ESCHERICHIA COLI; EXPERT SYSTEM; GENETIC SUSCEPTIBILITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCREENING; STRAIN DIFFERENCE; STRAIN IDENTIFICATION;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; ESCHERICHIA COLI; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; VIDEO RECORDING;

EID: 16844373837     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.4.1846-1850.2005     Document Type: Article

References (19)

1. Aubert, D., L. Poirel, J. Chevalier, S. Leotard, J.-M. Pages, and P. Nordmann. 2001. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 45:1615-1620.
2. Bert, F., Z. Ould-Hocine, M. Juvin, V. Dubois, V. Loncle-Provot, V. Lefranc, C. Quentin, N. Lambert, and G. Arlet. 2003. Evaluation of the Osiris expert system for identification of β-lactam phenotypes in isolates of Pseudomonas aeruginosa. J. Clin. Microbiol. 41:3712-3718.
3. Bert, F., C. Branger, and N. Lambert. 2004. Comparative activity of β-lactam agents against Pseudomonas aeruginosa strains with well-characterized ticarcillin-resistance mechanisms. Chemotherapy 50:31-34.
4. Bou, G., M. Cartelle, M. Tomas, D. Canle, F. Molina, R. Moure, J. M. Eiros, and A. Guerrero. 2002. Identification and broad dissemination of the CTX-M-14 β-lactamase in different Escherichia coli strains in the northwest area of Spain. J. Clin. Microbiol. 40:4030-4036.
5. Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
6. Cao, V., T. Lambert, D. Q. Nhu, H. K. Loan, N. K. Hoang, G. Arlet, and P. Courvalin. 2002. Distribution of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob. Agents Chemother. 46:3739-3743.
7. Chanawong, A., F. H. M'Zali, J. Heritage, J. H. Xiong, and P. M. Hawkey. 2002. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob. Agents Chemother. 46:630-637.
8. Comité de l'Antibiogramme de la Société Française de Microbiologie. 2004. Communiqué 2004. [Online.] Sociėté Française de Microbiologie, Paris, France. http://www.sfm.asso.fr/.
9. Girlich, D., L. Poirel, A. Leelaporn, A. Karim, C. Tribuddharat, M. Fennewald, and P. Nordmann. 2001. Molecular epidemiology of the integron-located VEB-1 extended-spectrum β-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J. Clin. Microbiol. 39:175-182.
10. Henquell, C. D., D. Sirot, C. Chanal, C. De Champs, P. Chatron, B. Lafeuille, P. Texier, J. Sirot, and R. Cluzel. 1994. Frequency of inhibitor-resistant TEM β-lactamases in Escherichia coli isolates from urinary tract infections in France. J. Antimicrob. Chemother. 34:707-714.
11. Jarlier, V., M.-H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility pattern. Rev. Infect. Dis. 10:867-878.
12. TEM genes. Antimicrob. Agents Chemother. 44:2709-2714.
13. Livermore, D. M. 1995. β-Lactamases in the clinical laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
14. Moland, E. S., J. A. Black, A. Hossain, N. D. Hanson, K. S. Thomson, and S. Pottumarthy. 2003. Discovery of CTX-M-like extended spectrum β-lactamases in Escherichia coli isolates from five U.S. states. Antimicrob. Agents Chemother. 47:2382-2383.
15. Natsch, S., C. Conrad, C. Hartmeier, and R. Schmid. 1998. Use of amoxicillin-clavulanate and resistance in Escherichia coli over a 4-year period. Infect. Control Hosp. Epidemiol. 19:653-656.
16. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
17. Saladin, M., V. T. Cao, T. Lambert, J. L. Donay, J. L. Herrmann, Z. Ould-Hocine, C. Verdet, F. Delisle, A. Philippon, and G. Arlet. 2002. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol. Lett. 209:161-168.
18. Stapleton, P., P. J. Wu, A. King, K. Shannon, G. French, and I. Phillips. 1995. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob. Agents Chemother. 39:2478-2483.
19. Tzelepi, E., P. Giakkoupi, D. Sofianou, V. Loukova, A. Kemeroglou, and A. Tsakris. 2000. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J. Clin. Microbiol. 38:542-546.